Stock Events

Stock Events

Denali Therapeutics (DNLI) Q3 2025 Earnings

11AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.8

-0.73

-0.66

-0.6

Details

Expected EPS

-0.710257

Actual EPS

-0.72

Surprise EPS

-0.01

Surprise Percent

+1.37%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.72 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.